Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06191874 · ClinicalTrials.gov registry record

Evaluation of Advanced Imaging and Visualization for Clinical Deep Brain Stimulation

A clinical trial, sponsored by Duke University.

Completed
Registry status
20
Enrollment target

NCT06191874: Completed study, sponsored by Duke University.

NCT06191874 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06191874 has completed, sponsored by Duke University.

COMPLETED
Registry status
20 participants
Enrollment target

Study Summary

The objective of this project is to evaluate next generation visualization tools and surgical targeting models for clinical deep brain stimulation (DBS). This study will evaluate the performance of HoloDBS software in comparison to the current standard (SOC) clinical planning tools to prepare for DBS surgery. The investigators hypothesize that HoloDBS will provide more detailed and anatomically useful information to the neurosurgeon and neurologist than the current clinical standard. The study team reviews electronic medical records (EMR) from patients who are undergoing DBS surgery. There are no study visits involved in this study as only data from standard clinical care will be used. All study activities are executed by the study team and there are no interventions.

Primary Outcome

Comparison of the post-operative position of the DBS electrode to the location that was defined in the standard-of-care plan and the HoloDBS plan. The distance was calculated for each hemisphere for each participant as the distance between the actual post-operative electrode location and the location defined in the SOC plan (indicated as SOC) and the distance between the actual post-operative electrode location and the location defined in the HoloDBS plan (indicated as HoloDBS).

Interventions

  • OTHER Standard-of-care (SOC) surgery plan
  • OTHER HoloDBS hypothetical surgery plan

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2024-03-01
Est. Completion 2025-05-29
Duke University

1,725 total trials

What the finished NCT06191874 record still lists

NCT06191874 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.

The record links to 0 conditions, and to 2 interventions - of which Standard-of-care (SOC) surgery plan is the first listed.

NCT06191874 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06191874 about?

NCT06191874 is a clinical study titled "Evaluation of Advanced Imaging and Visualization for Clinical Deep Brain Stimulation". The objective of this project is to evaluate next generation visualization tools and surgical targeting models for clinical deep brain stimulation (DBS). This study will evaluate the performance of HoloDBS software in comparison to the current standard (SOC) clinical planning tools to prepare for D...

What is the current status of trial NCT06191874?

This trial is currently completed. The enrollment target is 20 participants. The study started on 2024-03-01. Estimated completion is 2025-05-29.

What interventions are being tested in trial NCT06191874?

The interventions under investigation include: Standard-of-care (SOC) surgery plan (OTHER), HoloDBS hypothetical surgery plan (OTHER).

Who is sponsoring clinical trial NCT06191874?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06191874, the US trial registry maintained by the National Library of Medicine. NCT06191874 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.